1. Outcomes: Secondary outcomes include diarrhea, and antibiotic associated diarrhea. How will you define diarrhea in this population? How are you tracking diarrhea. How will you diagnosis antibiotic associated diarrhea. Will there be adjudication of the outcomes.
2. Intervention: will residents enrolled be given probiotics/placebo for the study period or only if they are on antibiotics? This could be clarified further in the manuscript.
3. Quality Assurance: will you be doing any testing on capsules to ensure patients are receiving the stated quantity of probiotic species.? Please Clarify 4. Ethics: the consent process could be made clearer. How does the study coordinator establish capacity? Is this standard at your centre? May be made similar with a figure.
5. Mechanistic study: this was exciting to see. Excellent translational research. Why are you checking vitamin D levels?
6. Statistical analysis: modify ITT please justify.
7. Interim Analysis: in the manuscript you state you did perform an interim analysis (page 6, line 45) then state you will not be performing an interim analysis. Please clarify.
8. Style: The manuscript could be streamlined. There are run on sentences that could be shortened.
VERSION 1 -AUTHOR RESPONSE

Comment
Response Changes made
The study design is ambitious in an area that is typically very challenging to obtain adequate data. In terms of the primary outcome, I have some concerns that this data may be unreliable. The authors do not specifically describe how antibiotic days will be obtained-review of Many thanks for these comments.
We did not have access to pharmacy records.
As stated in the manuscript under Thank you to the reviewer for the suggestion of this limitation, it has now been added.
Please bear in mind that this is a placebo controlled, individually randomised trial. Hence external initiatives aimed at enhancing antimicrobial stewardship will affect both arms. The point is well taken, however, overall reductions in antibiotic prescribing might result in fewer end points overall in both arms, resulting in less power than anticipated. We have therefore amended the strengths and limitations points.
Changes made under Strengths and limitations of the study -addition of following bullet point, and deletion of one of the others:
Recent antimicrobial stewardship guidance specifically for long-term care facilities could result in lower antibiotic prescribing rates during the trial.
Deletion of this text:
The intervention and followup for up to twelve months in a real-world setting and representative population.
Secondary outcomes include diarrhea, and antibiotic associated diarrhea. How will you define diarrhea in this population? How are you tracking diarrhea. How will you diagnosis antibiotic associated diarrhea. Will there be adjudication of the outcomes.
Many thanks for these comments.
Diarrhoea is defined as: 'the abnormal passing of loose or liquid stools, with increased frequency and/or increased volume' (NICE Clinical knowledge summaries). However, the norm for the participant was also considered when collecting this information as care home residents often have loose stools as a result of overflow, aperient use rather than an infective cause. Stool charts are kept in care homes that usually record stool consistency based on the Bristol Stool Chart, and our Research Nurses (RNs) will have access to these charts. We have trained our RNs to record the presence of loose stools.
The following items will be analysed (taken from the Statistical Analysis Plan): Antibiotic associated diarrhoea (incidence and cumulative days); all-
The following text has been added to the manuscript at the end of Outcomes:
Diarrhoea is defined as: 'the abnormal passing of loose or liquid stools, with increased frequency and/or increased volume' (NICE Clinical knowledge summaries). However, the norm for the participant was also considered when collecting this information as care home residents often have loose stools as a result of overflow, aperient use rather than an infective cause. Stool charts are kept in care homes that usually record stool consistency based on the Bristol Stool Chart, and our RNs will have access to these charts. We have trained our RNs to record the presence of loose stools.
cause diarrhoea (incidence and cumulative days); mean duration of diarrhoea episodes (i.e. mean duration of consecutive diarrhoea days).
We will not be adjudicating any of the outcomes.
Intervention: will residents enrolled be given probiotics/placebo for the study period or only if they are on antibiotics? This could be clarified further in the manuscript.
As stated under Intervention in original manuscript: "Participants will be asked to take an oral dose of probiotic (LGG and BB-12) or a matched placebo (containing maltodextrin, microcrystalline cellulose, magnesium stearate and silicon dioxide) as a capsule once daily for up to 12-months." This is irrespective of whether they are taking antibiotics or not. We have added a sentence in the manuscript to indicate that the study product will be continued even when on antibiotics and other medications.
The following text has been added to the manuscript under Intervention:
Study product will be continued even when on antibiotics and other medications.
Quality Assurance: will you be doing any testing on capsules to ensure patients are receiving the stated quantity of probiotic species? Please Clarify Nottingham University Hospitals NHS Trust received the bulk probiotic and bulk placebo (in tubes of one month's supply per study participant) in separate boxes from Chr. Hansen. They did their own in-house analyses so they could, if needed, identify them at a later date. Once labelled, samples of study product were cultured to confirm the presence of the probiotic organisms in the active and absence of the study probiotic organisms in the placebo, and this was checked against the allocation codes. These checks confirmed viability for the probiotic as well as correct labelling. The following text has been added to the manuscript under Mechanistic study samples:
Vitamin D enhances antiinfective activities of macrophages.
Statistical analysis: modify ITT please justify.
The modified intention to treat analysis maintains a comparison of participants as randomised (regardless of protocol deviations such as non-adherence or contamination). The primary analysis will be based on count data (Poisson or Negative Binomial regression), with an offset variable used to account for the total number of days a participant was observed. Missing data for those remaining in the study is likely to be low, given the high intensity of our data collection strategy, but not all participants will remain in the study for the full 12-months primarily due to death. We therefore believe that this is a sensible primary analysis, as it is randomisation respecting and accounts for the number of observed days. We will also conduct a series of sensitivity analyses that will account for departures from randomised treatment, missing data, and drop-out
The following text has been added to the manuscript at the end of Statistical analysis:
A detailed Statistical Analysis Plan (SAP) will be written and signed prior to any analysis commencing, this will detail the modified intention to treat analysis.
due to death. These will be fully described in our statistical analysis plan, which will be signed off prior to database lock and unblinding. This is covered under: Primary and secondary outcomes analysis
Interim Analysis: in the manuscript you state you did perform an interim analysis (page 6, line 45) then state you will not be performing an interim analysis. Please clarify.
We performed an "interim assessment" as part of an Internal Pilot Report to determine if we met the Stop/Go contractual criteria stipulated by the funders (successful recruitment; sufficient data collection at threemonth assessment; successful analyses of lab samples; interest from further care homes to partake in the trial). We did not perform an interim analysis for the full study.
The following text has been added to the manuscript under Primary outcome::
(to determine if we met the Stop/Go contractual criteria)
Style: The manuscript could be streamlined.
There are run on sentences that could be shortened
